HS code |
CIQ code |
HS System Commodity Name |
Gen Duty |
MFN Duty |
FTA Duty |
Excise Tax |
VAT |
Customs Clearance Code |
CIQ Inspection Code |
3002110000 |
|
Malaria diagnostic tesk kits
疟疾诊断试剂盒
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
AB |
P.V/Q.W |
3002120011 |
|
Erythropoietin(EPO)
唾液酸促红素、促红素衍生肽、氨甲酰促红素、达促红素、促红素(EPO)类等促红素
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120012 |
|
Mechano Growth Factor
胰岛素样生长因子1(IGF-1)及其类似物
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120013 |
|
Fibroblast growth factor
机械生长因子类
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120014 |
|
Hepatocyte growth factor
成纤维细胞生长因子类(FGFs)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120015 |
|
Platelet derived growth factor
肝细胞生长因子(HGF)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120016 |
|
Vascular endothelial growth factor
血小板衍生生长因子(PDGF)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120017 |
|
Vascular endothelial growth factor
血管内皮生长因子(VEGF)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120018 |
|
Transforming growth factor -β (TGF-β) inhibitors
转化生长因子-β (TGF-β)信号传导抑制剂类
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120019 |
|
Peinisha peptide, Roth Heap
培尼沙肽、罗特西普
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120021 |
|
Hypoxia inducible factor (HIF) activator, hypoxia inducible factor (HIF) stabilizer
缺氧诱导因子(HIF)激活剂类、缺氧诱导因子(HIF)稳定剂类
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120022 |
|
EPO-Fc (IgG4) fusion protein, EPO-Fc fusion protein
EPO-Fc(IgG4)融合蛋白、EPO-Fc融合蛋白
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABL |
P.V/Q.W |
3002120023 |
|
Antiserum and other blood,containing human genetic resources
含有人类遗传资源的抗血清及其他血份
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
ABV |
P.V/Q.W |
3002120091 |
|
Anti cancer preparations (excluding cancer adjuvant drugs)
抗(防)癌药品制剂(不含癌症辅助治疗药品)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
3.0% |
AB |
P.V/Q.W |
3002120092 |
|
Human coagulation factor_, recombinant human coagulation factor_for injection, recombinant human coagulation factor_for injection, recombinant human coagulation factor_a for injection and human prothrombin complex
人凝血因子Ⅷ、注射用重组人凝血因子Ⅷ、注射用重组人凝血因子Ⅸ、注射用重组人凝血因子Ⅶa、人凝血酶原复合物
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
3.0% |
AB |
P.V/Q.W |
3002120099 |
|
Antisera, other blood fractions and immunological products
其他抗血清及其他血份
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
AB |
P.V/Q.W |
3002130000 |
|
Immunological products,unmixed,not put up in measured doses or in forms or packings for retail sale
非混合的免疫制品,未配定剂量或制成零售包装
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
AB |
P.V/Q.W |
3002140000 |
|
Immunological products,mixed,not put up in measured doses or in forms or packings for retail sale
混合的免疫制品,未配定剂量或制成零售包装
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
13.0% |
AB |
P.V/Q.W |
3002150010 |
|
Immunological products,put up in measured doses or in forms or packings for retail sale
抗(防)癌药品制剂(不含癌症辅助治疗药品)
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
3.0% |
AB |
P.V/Q.W |
3002150020 |
|
Recombinant human interferon beta 1A injection
重组人干扰素β1a注射液
|
20.0% |
3.0% |
0% ~ 3.0% |
0.0% |
3.0% |
AB |
P.V/Q.W |